| 标题 |
 Efficacy of the triplet therapy with venetoclax, azacitidine and gilteritinib for the treatment of FLT3-ITD mutated AML patients with refractory/relapsed disease or persistent minimal residual disease bridging to allogeneic hematopoietic stem cell transplantation |
| 网址 | |
| DOI | |
| 其它 |
期刊：Blood 作者：Erlie Jiang; Chen Liang; Donglin Yang; Yi He; Aiming Pang; et al 出版日期：2025-12-05 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
Nole
DW
无极微光
Dean
学术文献互助
贪玩的秋柔
秋风
aaaa
Wells
dde
aajhajkahna
v0id
共产主义战士
Kao
鹰击长空
OK
arniu2008
Juvenilesy
xing_xing
皖公网安备34019202002308
